Granulomatous lung disease is a debilitating and sometimes fatal condition encountered in humans, for which the cellular and molecular mechanisms are poorly understood. Two patterns of granulomatous lung disease are recognized; foreign-body reactions and immune-mediated granulomas. Beryllium inhalation by humans results, in a small number of exposed individuals, in a chronic, granulomatous, immune-mediated pulmonary disease (chronic beryllium lung disease, CBD). Animal models used to study CBD have demonstrated significant species differences in the pathologic response to beryllium. While rats exposed to beryllium appear to develop a chronic, foreign-body response within the lung, dogs so exposed develop beryllium-specific immune responses within the lung and blood, accompanied by immune granulomas within the lung. At the heart of this difference appears to be the ability of the dog, but not the rat, to immunologically recognize the antigenicity of beryllium. This important difference further underscores the need to understand the mechanistic differences among similar disease syndromes, particularly if therapeutic regimens are to be used.
BorosDL (1986). Immunoregulation of granuloma formation in murine Schistosomiasis mansoni.Ann. NY Acad. Sci.465: 313–323.
4.
BoydenSV (1958). The immunological response to antigens of the tubercle bacillus. Some experimental aspects.Prog. Allergy5: 149–214.
5.
ChaparasSD (1982). The immunology of mycobacterial infections.CRC Crit. Rev. Microbiol.9: 139–192.
6.
ChensueSW, OtternessIG, HigashiGI, ForschCS, and KunkelSL (1989). Monokine production by hypersensitivity (Schistosoma mansoni EGG) and foreign body (sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor.J. Immunol.142: 1281–1286.
7.
ColleyDG (1973). Eosinophils and immune mechanisms. I. Eosinophil stimulation promoter (ESP): A lymphokine induced by specific antigen or phyto-hemagglutinin.J. Immunol.110: 1419–1423.
8.
CollinsFM (1982). The immunology of tuberculosis.Am. Rev. Respir. Dis.125: 42–49.
9.
CrystalRG, RobertsWC, HunninghakeGW, GadekJE, FulmerJD, and LineBR (1981). Pulmonary sarcoidosis: A disease characterized and perpetuated by activated lung T-lymphocytes within the lung.Ann. Intern. Med.94: 73–94.
10.
DanielTM (1980). The immunology of tuberculosis.Clin. Chest Med.1: 189–201.
11.
DannenburgAMJr. (1982). Pathogenesis of pulmonary tuberculosis.Am. Rev. Respir. Dis.125: 25–29.
12.
DauberJH, RossmanMD, and DanieleRP (1979). Bronchoalveolar cell populations in acute sarcoidosis; observations in smoking and nonsmoking patients.J. Lab. Clin. Med.94: 862–871.
13.
DaviesJD and NeelyJ (1972). The histopathology of peritoneal starch granulomas.J. Pathol.107: 265–277.
14.
DienesL and MalloryTB (1937). The influence of allergy on the development of early tuberculous lesions.Am. J. Pathol.13: 897–910.
15.
DoanCA, SabinFR, and ForknerCE (1930). The derivation of giant cells with especial reference to those of tuberculosis.J. Exp. Med.52, Suppl. 3: 89–112.
EdwardsD and KirkpatrickCH (1986). The immunology of mycobacterial diseases.Am. Rev. Respir. Dis.134: 1062–1071.
18.
EisenbudM and LissonJ (1983). Epidemiological aspects of beryllium-induced nonmalignant lung disease: A 30-year update.J. Occup. Med.25: 196–202.
19.
EliasPM and EpsteinWL (1968). Ultrastructural observations on experimentally induced foreign-body and organized epithelioid-cell granulomas in man.Am. J. Pathol.52: 1207–1223.
20.
EpsteinWL, SkahenJR, and KrasnobrodM (1962). Granulomatous hypersensitivity to zirconium: Localization of allergen in tissue and its role in formation of epithelioid cells.J. Invest. Dermatol.38: 223–232.
FinchGL, MewhinneyJA, EidsonAF, HooverMD, and RothenburgSJ (1988). In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols.J. Aerosol Sci.19: 333–342.
23.
ForknerCE (1930). The origin and fate of two types of multinucleated giant cells in the circulating blood.J. Exp. Med.52: 279–289.
24.
FreimanDG and HardyHL (1970). Beryllium disease; the relation of pulmonary pathology to clinical course prognosis based on a study of 130 cases from the U.S. beryllium case registry.Human Pathol.1: 25–44.
25.
HaleyPJ, FinchGL, MewhinneyJA, HarmsenAG, HahnFF, HooverMD, MuggenburgBA, and BiceDE (1989). A canine model of beryllium-induced granulomatous lung disease.Lab. Invest.61: 219–227.
26.
HaleyPJ, FinchGL, HooverMD, and CuddihyRG (1990). The acute toxicity of inhaled beryllium metal in rats.Fundam. Appl. Toxicol.15: 767–778.
27.
HaleyPJ, FinchGL, MewhinneyJA, HooverMD, MuggenburgBA, and BiceDE (1989). Beryllium-induced lung disease in the dog following repeated BeO exposure. In: Inhalation Toxicology Research Institute Annual Report 1988–1989, LMF-126, Springfield, NTIS, pp. 177–179.
28.
HooverMD, CastorinaBT, FinchGL, and RothenburgSJ (1989). Determination of the oxide layer thickness on beryllium metal particles.Am. Ind. Hyg. Assoc. J.50: 550–553.
29.
HunninghakeGW, GadekJE, KawanamiO, FerransVJ, and CrystalRG (1979). Inflammatory and immune processes in the human lung in health and diseases: Evaluation by bronchoalveolar lavage.Am. J. Pathol.97: 149–205.
30.
HunninghakeGW, GadekJE, YoungRCJr, KawanamiO, FerransVJ, and CrystalRG (1980). Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.New Engl. J. Med.302: 594–598.
31.
HunninghakeGW and CrystalRG (1981). Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.New Engl. J. Med.305: 429–434.
32.
JamesDG, NevilleE, and WalkerA (1975). Immunology of sarcoidosis.Am. J. Med.59: 388–394.
33.
KasaharaK., KobayashiK, ShikamaY, YoneyaI, SoezimaK, IdeH, and TakahashiT (1988). Direct evidence for granuloma-inducing activity of interleukin-1.Am. J. Pathol.130: 629–638.
34.
KonishiK., MollerDR, SaltiniC, KirbyM, and CrystalRG (1988). Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.J. Clin. Invest.82: 775–781.
35.
KrausseAK and PetersD (1920). Studies on immunity to tuberculosis. A description of graphic records of the local allergic and immune reactions to tuberculosis reinfections in guinea pigs.Am. Rev. Tuberc.4: 551–562.
36.
KunkelSL, ChensueSW, StrieterRM, LynchJP, and RemickDG (1989). Cellular and molecular aspects of granulomatous inflammation.Am. J. Respir. Cell Mol. Biol.1: 439–447.
37.
LurieMB (1964). Resistance to Tuberculosis: Experimental Studies in Native Acquired Defense Mechanisms.Harvard, Cambridge.
38.
MitchellDN and ScaddingJG (1974). Sarcoidosis.Am. Rev. Respir. Dis.110: 774–802.
39.
MooreDL, GroveDI, and WarrenKS (1977). The Schistosoma mansoni egg granuloma: Quantitation of cell populations.J. Pathol.121: 41–50.
40.
MorrowPE (1988). Possible mechanisms to explain dust overloading of the lungs.Fundam. Appl. Toxicol.10: 369–384.
41.
MyrvikQN, PearsallNN, and WeiserRS (1974). Mycobacterium. In: Fundamentals of Medical Bacteriology and Mycology.Lea and Febiger, Philadelphia, pp. 336–367.
42.
NewmanLS, KreissK, KingTEJr, SeayS, and CampbellPA (1989). Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.Am. Rev. Respir. Dis.139: 1479–1486.
43.
PinkstonP., BittermanPB, and CrystalRG (1983). Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.New Eng. J. Med.308: 793–800.
44.
von PirquetC (1906). Allergie.Munch. Med. Wschr.53: 1457–1458.
45.
PreussOP (1986). Health effects of beryllium and its components. In: Occupational Medicine, ZenzC (ed). Year Book Med Pub, Chicago, pp. 517–525.
RichAR (1951). The Pathogenesis of Tuberculosis.Thomas, Springfield.
48.
RobinsonBWS, McLemoreTL, and CrystalRG (1985). Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.J. Clin. Invest.75: 1488–1495.
49.
RossmanMD, KernJA, EliasJA, CullenMR, EpsteinPE, PreussOP, MarkhamTN, and DanieleRP (1988). Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease.Ann. Intern. Med.108: 687–693.
50.
RubinL., SlepyanAM, WeberLF, and NeuhauserI (1956). Granulomas of the axillas caused by deodorants.J. Am. Med. Assoc.162: 953–955.
51.
SabinFR (1938). Cellular reactions to tuberculo-proteins compared with the reactions to tuberculo-lipids.J. Exp. Med.68:837–851.
52.
SakulaA (1979). Robert Koch (1843–1910): Founder of the science of bacteriology and discoverer of the tubercle bacillus. A study of his life and work.Br. J. Dis. Chest73: 389–394.
53.
SaltiniC., SpurzemJR, LeeJJ, PinkstonP, and CrystalRG (1986). Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3 + DR + T cell subset.J. Clin. Invest.77: 1962–1970.
54.
SaltiniC., WinestockK, KirbyM, PinkstonP, and CrystalRG (1989). Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.N. Engl. J. Med.32: 1103–1109.
55.
SandersCL, CannonWC, PowersGJ, AdeeRR, and MeierDM (1975). Toxicology of high fired beryllium oxide inhaled by rodents.Arch. Environ. Health30: 546–551.
56.
SchepersGWH, DurkamTM, DelahuntAB, and CreedonFT (1957). The biological action of inhaled beryllium sulfate. A preliminary chronic toxicity study on rats.Arch. Ind. Health15: 32–58.
57.
SchriberRA and Zucker-FranklinD (1975). Induction of blood eosinophilia by pulmonary embolization of antigen-coated particles: The relationship to cell-mediated immunity.J. Immunol.114: 1348–1353.
58.
SendelbachLE, TrykaAF, and WitschiH (1989). Progressive lung injury over a one-year period after a single inhalation exposure to beryllium sulfate.Am. Rev. Respir. Dis.139: 1003–1009.
59.
SpectorWG (1976). Epithelioid cells, giant cells, and sarcoidosis.Ann. NY Acad. Sci.278: 3–6.
60.
UngarJ and MuggletonRW (1961). The production of experimental granulomatous lesions induced by injections of fatty acids and fractions of tubercle bacilli.Am. Rev. Respir. Dis.85: 76–80.
61.
VottoJJ, BartonRW, GiofriddoMA, ColeSR, McCormickJR, and ThrallRS (1987). A model of pulmonary granulomata induced by beryllium sulfate in the rat.Sarcoidosis4: 71–76.
62.
WarrenKS and BorosDL (1975). The schistosome egg granuloma: A form of cell-mediated immunity. In: Mononuclear Phagocytes in Immunity, Infection and Pathology, van FurthR. (ed). Blackwell, Oxford, pp. 1015–1028.
63.
WarrenKS, DomingoEO, and CowanRBT (1967). Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.Am. J. Pathol.51: 735–756.
64.
ZinsserH (1921). Studies on the tuberculin reaction and on specific hypersensitiveness in bacterial infections.J. Exp. Med.34: 495–524.
